The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABIOMED Inc | COM | 003654100 | 1,729 | 10,138 | SH | SOLE | NONE | 10,138 | 0 | 0 | |
| Aduro Biotech Inc | COM | 00739L101 | 160 | 135,898 | SH | SOLE | NONE | 135,898 | 0 | 0 | |
| Adverum Biotechnologies Inc | COM | 00773U108 | 366 | 31,799 | SH | SOLE | NONE | 31,799 | 0 | 0 | |
| Aerie Pharmaceuticals Inc | COM | 00771V108 | 4,543 | 187,976 | SH | SOLE | NONE | 187,976 | 0 | 0 | |
| AnaptysBio Inc | COM | 032724106 | 5,852 | 360,100 | SH | SOLE | NONE | 360,100 | 0 | 0 | |
| Apellis Pharmaceuticals Inc | COM | 03753U106 | 2,303 | 75,227 | SH | SOLE | NONE | 75,227 | 0 | 0 | |
| ArQule Inc | COM | 04269E107 | 11,877 | 595,018 | SH | SOLE | NONE | 595,018 | 0 | 0 | |
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 6,090 | 43,775 | SH | SOLE | NONE | 43,775 | 0 | 0 | |
| Aurinia Pharmaceuticals Inc | COM | 05156V102 | 2,564 | 126,533 | SH | SOLE | NONE | 126,533 | 0 | 0 | |
| Autolus Therapeutics PLC | SPON ADS | 05280R100 | 173 | 13,113 | SH | SOLE | NONE | 13,113 | 0 | 0 | |
| Cara Therapeutics Inc | COM | 140755109 | 4,578 | 284,170 | SH | SOLE | NONE | 284,170 | 0 | 0 | |
| Crinetics Pharmaceuticals Inc | COM | 22663K107 | 5,162 | 205,726 | SH | SOLE | NONE | 205,726 | 0 | 0 | |
| CytomX Therapeutics Inc | COM | 23284F105 | 3,956 | 476,110 | SH | SOLE | NONE | 476,110 | 0 | 0 | |
| Deciphera Pharmaceuticals Inc | COM | 24344T101 | 3,723 | 59,818 | SH | SOLE | NONE | 59,818 | 0 | 0 | |
| Dicerna Pharmaceuticals Inc | COM | 253031108 | 2,292 | 104,047 | SH | SOLE | NONE | 104,047 | 0 | 0 | |
| Epizyme Inc | COM | 29428V104 | 23,752 | 965,519 | SH | SOLE | NONE | 965,519 | 0 | 0 | |
| Frequency Therapeutics Inc | COM | 35803L108 | 938 | 53,510 | SH | SOLE | NONE | 53,510 | 0 | 0 | |
| G1 Therapeutics Inc | COM | 3621LQ109 | 10,953 | 414,408 | SH | SOLE | NONE | 414,408 | 0 | 0 | |
| IVERIC bio Inc | COM | 46583P102 | 14,170 | 1,651,471 | SH | SOLE | NONE | 1,651,471 | 0 | 0 | |
| MEI Pharma Inc | COM | 68752L100 | 8,722 | 185,618 | SH | SOLE | NONE | 185,618 | 0 | 0 | |
| NeoGenomics Inc | COM | 55279B202 | 7,750 | 3,125,000 | SH | SOLE | NONE | 3,125,000 | 0 | 0 | |
| OrthoPediatrics Corp | COM | 64049M209 | 5,802 | 198,348 | SH | SOLE | NONE | 198,348 | 0 | 0 | |
| PTC Therapeutics Inc | COM | 69366J200 | 9,401 | 195,725 | SH | SOLE | NONE | 195,725 | 0 | 0 | |
| Solid Biosciences Inc | COM | 83422E105 | 358 | 80,487 | SH | SOLE | NONE | 80,487 | 0 | 0 | |
| Sunesis Pharmaceuticals Inc | COM | 867328700 | 185 | 548,228 | SH | SOLE | NONE | 548,228 | 0 | 0 | |
| Tricida Inc | COM | 89610F101 | 2,666 | 70,653 | SH | SOLE | NONE | 70,653 | 0 | 0 | |
| US Physical Therapy Inc | COM | 90337L108 | 2,459 | 21,500 | SH | SOLE | NONE | 21,500 | 0 | 0 | |
| WaVe Life Sciences Ltd | COM | Y95308105 | 849 | 105,986 | SH | SOLE | NONE | 105,986 | 0 | 0 | |
| Y-mAbs Therapeutics Inc | COM | 984241109 | 5,836 | 186,749 | SH | SOLE | NONE | 186,749 | 0 | 0 | |